4 results match your criteria: "Hebrew University in Jerusalem Medical School[Affiliation]"
Occluded vein as a predictor for complications in non-infectious transvenous lead extraction.
Front Cardiovasc Med
October 2022
Leviev Heart Institute, The Chaim Sheba Medical Center, Ramat Gan, Israel.
Article Synopsis
- * Results show that patients with OV are older, have more comorbidities, lower ejection fractions, and longer lead dwelling times, leading to higher complications compared to those without occlusions.
- * The findings suggest that assessing for vein occlusion through venography before TLE can help identify patients at higher risk for complications and may require more complex extraction techniques.
Determinants of Response to Cardiac Resynchronization Therapy.
J Innov Card Rhythm Manag
May 2022
The Demoulas Center for Cardiac Arrhythmias, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Cardiac resynchronization therapy (CRT) is a well-established treatment modality for ambulatory patients with heart failure (HF) who have prolonged QRS, left bundle branch block, reduced left ventricular (LV) ejection fraction, and New York Heart Association class II-IV. CRT has been shown to induce reverse LV remodeling and improve HF symptoms and clinical outcomes. About one-third of CRT recipients are considered non-responders.
View Article and Find Full Text PDFLeft Bundle-Branch Block Tachycardia After Transcatheter Aortic Valve Replacement.
Circulation
October 2021
Heart Institute, Hadassah Medical Center, Hebrew University in Jerusalem Medical School, Israel (B.B., A.S., Y.B.).
For Whom the Bell Tolls : Refining Risk Assessment for Sudden Cardiac Death.
Curr Cardiol Rep
August 2019
Hadassah Medical Center, Heart Institute, Hebrew University in Jerusalem Medical School, Kyriat Hadassah, PO Box 12000, 91120, Jerusalem, Israel.
Sudden cardiac death is one of the most important causes of death worldwide. Advancements in medical treatment, percutaneous interventions, and device therapy (ICD and CRTD) showed consistent reduction in mortality, mainly in survivors of SCD and in patients with ischemic cardiomyopathy and depressed left ventricular function. Patients with non-ischemic cardiomyopathies, mildly reduced LV function, and channelopathies have increased risk for SCD.
View Article and Find Full Text PDF